Congenital Hematological Disorder Enrolling by Invitation Phase 3 Trials for Turoctocog alfa pegol (DB14738)

Also known as: Congenital Bleeding Disorder / Congenital bleeding disorders / Congenital haematological disorder

IndicationStatusPhase
DBCOND0081791 (Congenital Hematological Disorder)Enrolling by Invitation3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02137850Safety and Efficacy of Turoctocog Alfa Pegol (N8-GP) in Previously Untreated Patients With Haemophilia ATreatment